MBRX:NASDAQ
Moleculin Biotech Inc
$2.40
arrow_downward
-4.38%(-0.11) 1D
$2.47
arrow_upward
+3.08% (+0.074)bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBRX...
Open
$2.57
High
$2.60
Low
$2.37
Mkt. cap
12.81M
Avg. vol.
251.93K
Volume
225.86K
52-wk high
$24.00
52-wk low
$1.79
EPS
-$25.97
Beta
1.77
Shares outstanding
5.34M
No. of employees
17
Open
$2.57
High
$2.60
Low
$2.37
Mkt. cap
12.81M
Avg. vol.
251.93K
Volume
225.86K
52-wk high
$24.00
52-wk low
$1.79
EPS
-$25.97
Beta
1.77
Shares outstanding
5.34M
No. of employees
17
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to MBRX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MBRX in the last 3 months.
Highest
Current $2.40
$22.00 (+816.67%)
Average
$16.00 (+566.67%)
Lowest
$10.00 (+316.67%)
News stories
From sources across the web
TipRanks
·
2 days ago
Moleculin Highlights Strong Market Interest in Annamycin AML Therapy
Stock Titan
·
2 days ago
Strong physician interest in Annamycin reported by Moleculin (NASDAQ: MBRX)
Stock Titan
·
2 days ago
Leukemia drug Annamycin wins doctor and insurer support in new survey
About Moleculin Biotech Inc
CEO-
Employees17
Founded2015
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitemoleculin.com
AI content may include mistakes. Learn more